| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Aumann AG
Aumann AG
XETRA:AAG
Aumann AG
Other Liabilities
Aumann AG
Other Liabilities Peer Comparison
KRN
PFV
G1A
RAA
GIL
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Aumann AG
XETRA:AAG
|
Other Liabilities
€16.2m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
Krones AG
XETRA:KRN
|
Other Liabilities
€402.6m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
Pfeiffer Vacuum Technology AG
XETRA:PFV
|
Other Liabilities
€45.7m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
5%
|
|
|
GEA Group AG
XETRA:G1A
|
Other Liabilities
€755.8m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
|
|
Rational AG
XETRA:RAA
|
Other Liabilities
€18.3m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
17%
|
|
|
DMG Mori AG
XETRA:GIL
|
Other Liabilities
€97.9m
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
4%
|
See Also
What is Aumann AG's Other Liabilities?
Other Liabilities
16.2m
EUR
Based on the financial report for Mar 31, 2024, Aumann AG's Other Liabilities amounts to 16.2m EUR.
What is Aumann AG's Other Liabilities growth rate?
Other Liabilities CAGR 5Y
-4%
Over the last year, the Other Liabilities growth was 5%. The average annual Other Liabilities growth rates for Aumann AG have been -12% over the past three years , -4% over the past five years .
You don't have any saved screeners yet
